ABSTRACT
Introduction
The Small-for-Size Syndrome (SSS) is seen more often if the transplanted segment of the donor is <30% liver or <0.8% of body weight of the recipient 1 . The SSS is a complex process resulting primarily from ischemia-reperfusion injury (IRI) and portal hypertension associated with mismatch between the graft and recipient size. In the initial period, the molecular events associated with subsequent apoptosis, necrosis, proliferation and regeneration appeared in specific patterns of protein expression [2] [3] [4] .
The diagnosis of SSS graft is generally based on persistent hyperbilirubinemia, coagulopathy, massive ascites during subacute phase post-transplant or extensive hepatic resection 2, 5 . Living donor liver transplantation can reduce the discrepancy between the number of patients on the waiting list for transplantation and the number of donor organs available.
Stem cells have three properties: self-renewal, proliferation and differentiation. They have the potential to generate large numbers of mature cells continuously throughout life 6, 7 . The term refers to cells having ability to generate daughter cells with characteristics similar to the mother cell, as well as differentiate into specialized cells 6, 7 . Stem cells are able to differentiate into all cell types and can be used in replacement therapies for various diseases. Embryonic and fetal liver cell lines can be an important tool for cell therapy in patients with liver disease source, as they have a high rate of differentiation into hepatocytes and bile duct cells. Although there are numerous published papers on the administration of stem cells, none of them evaluate the best route of administration. The aim of this study was to evaluate which is the best route of administration for cell therapy in experimental rat model of liver regeneration on small-for size-syndrome.
Methods
The study was designed in accordance with the Guide Two or three animals from the same treatment group were housed per cage. The animals had free access to tap water and standard food during the entire experiment. Food intake was not measured.
Study design
The animals underwent an extended partial hepatectomy 
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Incorporation of Propidium Iodide (PI) and reading sample
The fixed and previously stored samples were centrifuged at 2000 rpm for 5 minutes. The supernatant was discarded, the cells resuspended in 1 ml flow cytometry buffer and centrifuged again.
After centrifugation, the supernatant was discarded and the cells resuspended in PI solution prepared from 5 ml PBS (sodium phosphate buffer pH 7.4) to which were added 100 5μL Triton (0.01% v/v) and 50μL of RNAse (2mg/mL) and 20μL of propidium iodide (5mg/mL).
Then, if the held data acquisition FACSCalibur flow cytometer on 10.000 events for analysis and Win Mdi 2.8 program was used.
Evaluation of routs administration of stem cell in rats
Initially, we performed the analysis in the seventh day after surgery; follow by second analysis in fifteenth day and subsequent twentieth day for establishing and detecting the stem cell by PET-scan, ultrasonography and radiography for each route administration group.
Literature review
A literature review was performed with the Mesh-terms "Liver regeneration"; "Disease models, Animal"; "Stem cells" and "Rats". The electronic search was held of the Medline-PubMed, in
English. The search was completed in September 2014.
Statistics
Statistical analysis was performed using GraphPad Prism Software ® . Differences were considered significant with the p<0.05. Data are presented as the median and variation for continuous variables. Comparisons between groups were made using analysis of the imaging test by the researchers.
Results
A total of 40 rats underwent partial hepatectomy that induces the small-for-size syndrome and the four groups of routes administration were evaluated in three moments (seventh, fifteenth and twenty-first day). They were carried out as follows:
intravenous group (n=10), intraperitoneal group (n=10), enteral group (n=10) and tracheal group (n=10). All four groups underwent partial hepatectomy of 70% liver tissue targeting the same weight of resected liver. The routes of administration for cell therapy in experimental rat model of small-for size syndrome for each group were evaluated using ultrasound, radiography and displayed below the PET-scan ( Figure   4 ). During follow-up of twenty-one days, the cells remained alive after administration in all groups showed by PET-scan. Initially it was observed in PET-scan tests a similarity between administered cells by different routes. However, after few days the intravenous route showed to be more appropriated to lead cells to the liver, followed by enteral route. The tracheal and peritoneal routes were not as much efficient for this ultimate goal.
The evaluation by ultrasound and radiography of the rats, in the different groups showed no differences to show the marked stem cell ( Figure 5 ). In the laboratory analysis, we observed an elevation of liver enzymes (AST and ALT), slight change of total and direct bilirubin, and extending the coagulation time. Forty percent of the cases presented incoagulable value in the sample (Table 1) .
A literature review was performed with the Mesh-terms: It is interesting to notice that the enteral route was better than peritoneal and tracheal routes, and it showed to be also a good route of administration. Other important point is that the enteral route of administration (gavage tube) was placed after the stomach, preventing the acid acting on the cells. It is remarkable that the tracheal route group showed a representative amount of viable marked stem cells in the liver.
Although we did not find any study using this way of administration in our review, this is also an option for specific studies, and it demonstrates the high absorption capacity of the animal in different sites when stem cells are administrated. By the literature review with 69 articles in Medline-PubMed, the most common route of infusion was intravenous in 62% of specific articles, followed by intraesplenic (12%) and intraperitoneal (12%).
Salomone et al. 6 showed the efficacy of stem cell transplantation in rats with acetaminophen liver injury on Sprague-Dawley rats that were administrated 300mg/kg of acetaminophen intraperitoneally. The therapy was performed in six rats that received the infusion of stem cells via the caudal vein. They injected around 200.000 cells suspended in 1 mL of saline solution and six rats were administrated only saline.
In this study, as an example, the authors used the intravenous administration.
The hepatocyte transplantation in animal models showed the intraportal route has been used in animal models of metabolic liver disorders. However, the peritoneal cavity and subcutaneous tissues have been investigated and these sites do not efficiently support cell viability for long periods because the transplanted cells have no direct and instant access to oxygen and nutrients 8 . Another study demonstrated the contribution of mature hepatocytes to small hepatocyte-like progenitor cells in retrorsine-exposed rats with chimeric livers that was administrated via intraportal 7 .
The spleen has proven to be also a good site for hepatocyte engraftment. The hepatocytes infused into the portal vein or infused into the spleen undergo blood flow-mediated translocation to the hepatic sinusoids. However, a large proportion remains in the spleen, which can serve as a site for long-term survival and function of engrafted hepatocytes. Intrasplenic hepatocyte transplantation has been performed in animal models of chronic liver failure 8 .
Ultimately, the intravenous route of administration was more appropriate to aim in the liver place, followed by enteral.
All four routes tested showed to lead cells to the liver even the tracheal route. The intravenous route, as the most used, confirmed to be the best route for cells administration in rats models for liver regeneration.
Conclusion
The intravenous route is the best one to cell therapy in experimental rat model of small-for size-syndrome.
